ATLASRelay Therapeutics (RLAY) earnings date: Nov 5, 2026
Relay Therapeutics (RLAY) reports earnings for the quarter ended Sep 30, 2026 on Thu, Nov 5, 2026, after the close. Analysts expect EPS of -$0.40.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on RLAY
| Last price | $18.35 (-5.8%) |
|---|---|
| Normal 1-day range (±1σ) | ±3.5% |
| Earnings beat history | Beat the EPS estimate in 2 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Relay Therapeutics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Relay Therapeutics reports on Nov 5, 2026. One email the day before, with ATLAS’s read on Relay Therapeutics. You can switch it off at any time.
Alert me before RLAY reportsFree to start. Creating an account takes under a minute.
RLAY earnings at a glance
| Next report (confirmed) | Thu, Nov 5, 2026 |
|---|---|
| Time | After the close |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.40 |
| Last report | Aug 6, 2026 · Miss |
| Beat rate (last 5 reports) | 2 of 5 (40%) |
| Average EPS surprise | +17.3% |
| Average move around a report | ±5.4% (last 5) |
| Sector | Healthcare · Biotechnology |
Relay Therapeutics earnings history: last 5 reports
Relay Therapeutics last reported on Aug 6, 2026: EPS of -$0.41 against an estimate of -$0.39 (-5.1% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 6, 2026 | -$0.39 | -$0.41 | -5.1% | Miss | +0.4% |
| May 5, 2026 | -$0.36 | -$0.41 | -13.9% | Miss | -1.3% |
| Mar 10, 2026 | -$0.27 | -$0.04 | +85.2% | Beat | +6.5% |
| Feb 26, 2026 | -$0.40 | -$0.31 | +22.5% | Beat | +11.3% |
| Nov 6, 2025 | -$0.42 | -$0.43 | -2.4% | Miss | -7.6% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for RLAY
See the fair value, the probability range and the earnings history of Relay Therapeutics on its ATLAS page.
Relay Therapeutics (RLAY) stock analysisPlans from €3.99 a month.
Relay Therapeutics earnings: frequently asked questions
When does Relay Therapeutics (RLAY) report earnings?
Relay Therapeutics is scheduled to report on Thursday, November 5, 2026, after the close. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for RLAY?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.40 per share (USD). Estimates can change before the report.
How often does RLAY beat earnings estimates?
Of its last 5 reports with a recorded result, Relay Therapeutics beat the EPS estimate 2 times; the average surprise was +17.3%. Past results do not predict the next one.
How much does RLAY move around earnings?
Over its last 5 reports the stock moved an average of 5.4% (absolute, from the close before the report day to the close after it), and finished higher 3 of 5 times.
Did Relay Therapeutics beat earnings estimates last quarter?
Relay Therapeutics last reported on Aug 6, 2026: EPS of -$0.41 against an estimate of -$0.39 (-5.1% surprise), a miss.
How much does RLAY usually move in a day?
On a normal trading day the ATLAS model puts RLAY’s one-day range at about ±3.5%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Thu, Nov 5, 2026
Educational information, not investment advice. Disclaimer